Physician profile
Mark A Reynolds
NPI 1659344810
$7,521.15
in general payments reported to CMS, 2019-2025
26 companies · $4,912 in 2025
The $4,912 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $1,604 · 2021: $41.43 · 2022: $543 · 2023: $127 · 2024: $175 · 2025: $4,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,302 · Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,301.73 |
| Food and Beverage | $912.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,733.43 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,566.73 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $387.95 | 2022 | |
| Janssen Pharmaceuticals, INC | $127.17 | 2025 | Invega Sustenna |
| Heron Therapeutics, INC. | $97.80 | 2022 | |
| Innovation Technologies INC | $68.55 | 2024-2025 | Irrisept |
| Lemaitre Vascular, INC. | $59.77 | 2023-2024 | Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium) |
| Avita Medical Americas, LLC | $58.99 | 2024 | |
| Covidien LP | $37.89 | 2019 | |
| Sanara Medtech INC. | $35.80 | 2020-2025 | Celleraterx |
| Baxter Healthcare | $34.19 | 2023 | Tisseel |
| Depuy Synthes Sales INC. | $34.03 | 2020 | |
| Hologic Sales and Service, LLC | $31.18 | 2023 | Localizer, Trident Specimen Radiography System |
| Csl Behring | $31.12 | 2019 | |
| Kyowa Kirin, INC. | $27.22 | 2024 | Crysvita |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $26.92 | 2023 | Phasix Mesh |
| Tela Bio, INC. | $25.46 | 2021 | |
| Ambu INC. | $25.09 | 2022 | |
| Allergan, INC. | $16.67 | 2022 | |
| Kls-Martin L.P. | $15.97 | 2021 | |
| Abbvie INC. | $15.14 | 2022 | |
| Elucent Medical | $14.21 | 2025 | |
| Tetraphase Pharmaceuticals, INC. | $14.04 | 2019 | |
| Medline Industries LP | $12.91 | 2019 | |
| Polynovo North America LLC | $11.99 | 2023 | |
| Kci USA, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.